MediPines AGM100® Launched for Perioperative Screening at 2 Leading Medical Centers

10 Sep 2019 Medical

NEWS PROVIDED BY MediPines 

Sep 10, 2019, 13:33 ET


ORANGE COUNTY, Calif., Sept. 10, 2019 /PRNewswire/ — MediPines Corporation in Orange County, CA announces the launch of the MediPines Gas Exchange Monitor (AGM100) in two major East and West Coast hospitals. The AGM100 is being deployed to support screening and stratification of surgical patients for risks in perioperative settings. Postoperative pulmonary complications (PPC) are common and recent studies suggest that they occur in 33% of high-risk patients and result in an estimated increase of $25,000, per case, in hospital expenses.  

Clinical Value of the MediPines Gas Exchange Monitor (AGM100 ®)

A leading academic medical center director stated, “Quite frankly, over 15% of our surgical patients have COPD and many more don’t know they have respiratory issues. That is why we are using the MediPines Gas Exchange Monitor (AGM100) to efficiently help screen and risk stratify these patients, before surgery.”

Built on MediPines’ innovative technology and on respiratory concepts pioneered by Dr. John B. West, a world-renowned respiratory physiologist, the AGM100:

  • Provides a fast, objective measure of pulmonary gas exchange.
  • Provides unique and innovative measurements of Oxygen Deficit, calculated arterial blood oxygen level (gPaO2™), PETCO2, and other valuable parameters and indices.
  • Provides results in under 2 minutes from a patient’s normal breathing sample.
  • Is portable, noninvasive, and designed for point-of-care settings.
  • Is ideally suited for high throughput environments, such as the pre-operative evaluation area.

How Can the AGM100 ® Improve Practice?

“This device is as much about empowering patients as it is about empowering clinicians. It allows patients to make more informed decisions about their care choices and provides a better opportunity for patients and clinicians to have matching expectations about surgical risks,” stated Richard Hinds, MediPines’ Medical Director.

Clinicians across the country face growing surgical workloads and have limited time to evaluate a patient’s respiratory status. In the backdrop of outcome-based evaluation in healthcare, reducing post-operative pulmonary complications is a high-value priority for clinicians and hospital providers.

“We are very excited about partnering with leading hospitals on both coasts and providing clinicians with a more complete picture of a patient’s pre-surgical respiratory status, intended to improve patient outcomes,” stated Steve Lee, MediPines CEO.

To schedule a meeting tailored to your clinical situation and needs, and to learn more about how the AGM100® can benefit your practice, click here.

About MediPines:

MediPines Corporation, based in Orange County, California, and manufacturer of the FDA 510(k) cleared MediPines Gas Exchange Monitor®, is a pioneering medical device company established to advance respiratory medicine. For more information, visit https://medipines.com.  

SOURCE MediPines

https://www.prnewswire.com/news-releases/medipines-agm100-launched-for-perioperative-screening-at-2-leading-medical-centers-300915304.html?tc=eml_cleartime

Respiratory Physiology – John B. West Lecture Series Launched by UC San Diego School of Medicine and MediPines

17 Jul 2019 Medical

ORANGE COUNTY, Calif., July 17, 2019 /PRNewswire/ — UC San Diego School of Medicine and MediPines Corporation, a medical device company based in Orange County, California announce the establishment of the “John B. West Distinguished Lecture Series in Respiratory Physiology and Pathophysiology” to help advance the field of respiratory medicine. The inaugural lecture will feature noted scholar, Joe G. N. Garcia M.D., from the University of Arizona College of Medicine-Tucson and will take place on July 29th, 2019 at the T. Denny Sanford Medical Education and Telemedicine Center, UC San Diego School of Medicine in La Jolla, California.

This distinguished lecture series, established in honor of Dr. John B. West, will bring together leading respiratory science researchers and physiologists to present their research findings to faculty-physicians within the Division of Pulmonary, Critical Care and Sleep Medicine, as well as other local physicians-scientists and clinicians, for the purpose of understanding the latest research and its impact on respiratory medicine. For more information on the lecture series visit the UC San Diego John B. West Lecture Series page.

Dr. West is a world-renowned respiratory physiologist, who has contributed six decades of invaluable research to the field of respiratory physiology and medicine. He is the author of the widely respected medical textbook West’s Respiratory Physiology: The Essentialsnow in its tenth edition. He is also the creator of a series of YouTube videos on respiratory physiology that have influenced the study and clinical practice of many medical students and practitioners worldwide.

“It is a great privilege to establish this lectureship series in honor of Dr. John B. West and his lasting impact on respiratory physiology,” stated Dr. Jason Yuan, Professor and Director of the Section of Physiology, Division of Pulmonary, Critical Care and Sleep Medicine at UC San Diego. “The field of respiratory physiology requires a multi-disciplinary translational approach to scientific advancement and UC San Diego is uniquely positioned to lead such efforts, as UC San Diego School of Medicine is home to Dr. West and several other renowned scientists in the field of respiratory physiology and pathophysiology.” 

UC San Diego School of Medicine’s Section of Physiology of the Division of Pulmonary, Critical Care and Sleep Medicine is home to several noted scholars:

The American Physiological Society Presidents

  • Dr. John B. West, 1984-85
  • Dr. Shu Chien, 1990-91
  • Dr. Peter Wagner, 2010-11
  • Dr. Kim Barrett, 2013-14

American Thoracic Society (ATS) Presidents

  • Dr. Atul Malhotra, 2015-16
  • Dr. Peter D. Wagner, 2005-06
  • Dr. Kenneth Moser, 1985-86 (Former chief of the Division of Pulmonary and Critical Care Medicine,1929-1997)

In addition, the UC San Diego Section of Physiology is the home of the editorial office for the journal, Pulmonary Circulation (Sage), of which Dr. Jason Yuan is the founding Editor-in-Chief. UC San Diego is a leading research institution and clinical hub dedicated to respiratory physiology and lung disease. 

Advancement in respiratory medicine is a national health priority.  A few years ago, a chronic lung disease, chronic obstructive pulmonary disease (COPD), was the fifth leading cause of death in the US. Today, COPD is the third leading cause of death in the US according to the American Lung Association and it is projected to become the world’s leading cause of death in the next 15 years.

COPD and Respiratory Challenges

  • Approximately 33 million Americans suffer from chronic or acute respiratory illness.
  • Respiratory disease accounts for ten percent of all emergency department visits, according to the Centers for Disease Control and Prevention (CDC).
  • In the United States, the economic cost attributed to COPD is estimated to be about $50 billion a year according to the COPD Foundation.
  • Studies estimate that 328 million people worldwide have COPD and it is expected to become the leading cause of death by 2035.

Unfortunately, respiratory disease has received far too little attention and funding in comparison with other major causes of global morbidity and mortality. The result is that respiratory illness is developing into a major public health crisis.

“It is timely that UC San Diego School of Medicine, a scientific and medical authority, is establishing a global forum to discuss medical advancement in the field of respiratory physiology,” stated Steve Lee, CEO of MediPines. “We need a multifaceted approach to tackle this national problem, including medical advancement, industry innovation, and forward-looking government policy. MediPines is delighted to partner with UC San Diego School of Medicine to launch this all-important lecture series in respiratory physiology and medicine.”

MediPines Corporation was established to advance respiratory medicine and it recently launched a novel respiratory device called the MediPines Gas Exchange Monitor, which is based on UC San Diego’s innovative medical technology.

About MediPines:

MediPines Corporation, based in Orange County, California, and maker of the FDA 510(k) cleared MediPines Gas Exchange Monitor, is a pioneering medical device company established to advance respiratory medicine. For more information, email contact@medipines.com, call (949) 398-4670, or visit https://medipines.com.

SOURCE MediPines

https://www.prnewswire.com/news-releases/respiratory-physiology—john-b-west-lecture-series-launched-by-uc-san-diego-school-of-medicine-and-medipines-300886801.html

FDA Cleared MediPines Gas Exchange Monitor Measures Freedivers’ Lung Efficiency in Ground-Breaking Study

12 Apr 2019 Medical

Successful Study Findings Unveiled by University of British Columbia Researchers at International Conference in Orlando, Florida

PR Newswire

ORANGE COUNTY, Calif., April 12, 2019 /PRNewswire/ — Novel physiologic results on world elite freedivers’ using the non-invasive MediPines Gas Exchange Monitor (https://bit.ly/2YVAG1M) were presented at the Experimental Biology 2019 conference. Dr. Philip Ainslie, Co-Director of the Centre for Heart, Lung and Vascular Health at the University of British Columbia, with his research team, conducted the study in Split, Croatia.

MP DIVER

The recently FDA 510(k) cleared, MediPines Gas Exchange Monitor is a breakthrough, portable respiratory monitoring device invented to provide real-time, clinically actionable data. This ground-breaking technology is transforming the approach to measuring pulmonary gas exchange in a wide variety of clinical settings, relevant for the 33 million patients in the US (350 million globally), who suffer from respiratory disease.

The physiological demands placed on these world-class athletes are tremendous. “The transient stress on their lungs is similar to what is observed in patients who suffer from cardiac and respiratory disease.” It has been challenging, in the past, to assess the consequences of deep dives on pulmonary gas exchange, especially during true field-based conditions. “Measuring oxygen deficit has allowed us to establish the impact of ‘lung squeeze’ on gas exchange inefficiency in elite freedivers,” stated Dr. Philip Ainslie.

Oxygen deficit was developed for detecting gas exchange inefficiency using a simple, non-invasive method.  “Understanding gas exchange inefficiency in respiratory patients is fundamental to improving patient outcomes,” according to Dr. John B. West, the world-renowned physiologist who pioneered the concept.

Freedivers place themselves in extreme conditions, which push the outer limits of human lung physiology and can lead to high oxygen deficit. The device provided rapid feedback to the research team tasked with assessing the freedivers’ gas exchange status. “We hope that our device will continue to aid clinicians by providing patients’ respiratory status rapidly and conveniently in situations where direct gas exchange measurement is either difficult or impossible; the device also has clear application to field-based conditions,” said Steve Lee, CEO of MediPines. 

About MediPines:

MediPines Corporation, based in Orange County, California, is a pioneering medical device company established to advance respiratory medicine. For more information, visit https://www.new.medipines.com/.

For more information about University of British Columbia’s Centre for Heart, Lung and Vascular Health, visit https://chlvh.ok.ubc.ca/.

(PRNewsfoto/MediPines)
Cision

View original content to download multimedia:http://www.prnewswire.com/news-releases/fda-cleared-medipines-gas-exchange-monitor-measures-freedivers-lung-efficiency-in-ground-breaking-study-300831089.html

SOURCE MediPines

MediPines Announces FDA Clearance of Breakthrough Respiratory Device, the MediPines Gas Exchange Monitor

30 Jan 2019 Medical

ORANGE COUNTY, Calif., Jan. 29, 2019 /PRNewswire/ — MediPines Corporation announced today it has received FDA 510(k) market clearance on its new non-invasive medical device, the MediPines Gas Exchange Monitor. The MediPines Gas Exchange Monitor provides clinicians with real-time pulmonary parameters and insights to support rapid triage and treatment decisions for respiratory conditions.


The MediPines Gas Exchange Monitor is the first technology of its kind to integrate a comprehensive set of respiratory parameters and innovative indices analyzed from a patient’s normal breathing samples in a simple, easy to administer breathing test in only a few minutes.

SOURCE: https://www.prnewswire.com/news-releases/medipines-announces-fda-clearance-of-breakthrough-respiratory-device-the-medipines-gas-exchange-monitor-300785572.html

Search

+